ArticleERJ open research2025
Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial.
Frederico Friedrich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it